Jump to Header Jump to Main Content Jump to Footer

PhII/IIIRminiCHOP w/or w/oCC-486 inPts75 orOlder w/DLBCL, Gr.IIB FL, TL w/MYC&BCL2&/orBCL6 Rearrange

Elizabeth A Brem


A Study On:

  • Non-Hodgkin's Lymphoma
  • Lymphoid Leukemia
  • Other Hematopoietic

Status:

  • Open

Eligibility

Adults

Interested in joining this trial?

Official Title

A Phase II/III Randomized Study of R-miniCHOP with or without Oral Azacitidine (CC-486) in Participants Age 75 Years or Older with Newly Diagnosed Diffuse Large B-Cell Lymphoma, Grade IIB, Follicular Lymphoma, Transformed Lymphoma, and High-Grade B-Cell Lymphomas with MYC and BCL2 and/or BCL6 Rearrangements

Details

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma


Eligibility

You can join if...

AM I ELIGIBLE TO PARTICIPATE IN THIS STUDY?

Please note this may not be a complete list of eligibility criteria. We have included a few examples of study criteria to help you better understand how your eligibility in the study will be determined; your study team will go through the study eligibility criteria with you to verify if you qualify for participation in this study.

Inclusion Requirements

You can participate in this study if you

  • are 75 years of age or older

Exclusion Requirements.

You cannot participate in this study if you

  • are currently receiving any other investigational drugs

Get in touch with our study team